Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...
In his final two years with the Seattle Seahawks, Carroll took Kenneth Walker III in the second round of the 2022 Draft and ...
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $166 from $162 and keeps a Neutral rating on the ...
Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...